2022 annual financial data
Tarsus Pharmaceuticals 2022 Operating margin
Tarsus Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -242.92%.
Operating income was -62,712,000 USD and net income was -62,091,000 USD.
Operating cash flow was -49,030,000 USD.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,816,000 USD
- Operating income
- -62,712,000 USD
- Net income
- -62,091,000 USD
- Operating cash flow
- -49,030,000 USD